SHSE:688580 (China)
Â
Class A
Â¥
21.61
(-3.14%)
Aug 23
Business Description
Nanjing Vishee Medical Technology Co Ltd
ISIN : CNE1000041Q0
Share Class Description:
SHSE:688580: Class ACompare
Compare
Traded in other countries / regions
688580.China IPO Date
2020-07-21Description
Nanjing Vishee Medical Technology Co Ltd is engaged in production and sales of rehabilitation medical devices. The company's products under Pelvic floor and postpartum rehabilitation include Pelvic floor electromyography biofeedback instrument; Myotrac series biological stimulation feedback instrument; Ruiyi Series Biostimulation Feedback Apparatus; Magneuro Series Magnetic Stimulator; Female psychological rehabilitation; Neonatal electroencephalograph; Consumables; and under Mental rehabilitation include Multi-parameter biofeedback instrument; Group biofeedback; Magneuro Series Magnetic Stimulator; and Cognitive dysfunction treatment software.
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 899.67 | |||||
Equity-to-Asset | 0.92 | |||||
Debt-to-EBITDA | 0.01 | |||||
Interest Coverage | 87.37 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 10.17 | |||||
Beneish M-Score | -1.92 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 1.4 | |||||
3-Year EBITDA Growth Rate | -5.8 | |||||
3-Year EPS without NRI Growth Rate | -10.3 | |||||
3-Year FCF Growth Rate | -82.6 | |||||
3-Year Book Growth Rate | 4.8 | |||||
Future 3-5Y EPS without NRI Growth Rate | 27.72 | |||||
Future 3-5Y Total Revenue Growth Rate | 22.55 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 5.69 | |||||
9-Day RSI | 16.55 | |||||
14-Day RSI | 25 | |||||
6-1 Month Momentum % | -32.29 | |||||
12-1 Month Momentum % | -38.07 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 10.53 | |||||
Quick Ratio | 10.18 | |||||
Cash Ratio | 9.61 | |||||
Days Inventory | 114.97 | |||||
Days Sales Outstanding | 24.41 | |||||
Days Payable | 52.39 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 6.75 | |||||
Dividend Payout Ratio | 0.36 | |||||
Forward Dividend Yield % | 6.75 | |||||
5-Year Yield-on-Cost % | 6.75 | |||||
3-Year Average Share Buyback Ratio | -0.1 | |||||
Shareholder Yield % | 6.61 |
Profitability Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 71.54 | |||||
Operating Margin % | 25.27 | |||||
Net Margin % | 28.16 | |||||
FCF Margin % | -6.11 | |||||
ROE % | 8.03 | |||||
ROA % | 7.29 | |||||
ROIC % | 20.44 | |||||
ROC (Joel Greenblatt) % | 49.52 | |||||
ROCE % | 8.71 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 16.43 | |||||
Forward PE Ratio | 12.61 | |||||
PE Ratio without NRI | 16.07 | |||||
Shiller PE Ratio | 19.15 | |||||
Price-to-Owner-Earnings | 32.92 | |||||
PEG Ratio | 3.28 | |||||
PS Ratio | 4.63 | |||||
PB Ratio | 1.28 | |||||
Price-to-Tangible-Book | 1.42 | |||||
Price-to-Operating-Cash-Flow | 15.91 | |||||
EV-to-EBIT | 7.03 | |||||
EV-to-EBITDA | 7.03 | |||||
EV-to-Revenue | 2.18 | |||||
EV-to-FCF | -35.74 | |||||
Price-to-Projected-FCF | 1.21 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.54 | |||||
Price-to-Graham-Number | 1 | |||||
Price-to-Net-Current-Asset-Value | 1.93 | |||||
Price-to-Net-Cash | 2.14 | |||||
Earnings Yield (Greenblatt) % | 14.22 | |||||
FCF Yield % | -1.32 | |||||
Forward Rate of Return (Yacktman) % | 13.01 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Nanjing Vishee Medical Technology Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 454.353 | ||
EPS (TTM) (Â¥) | 1.338 | ||
Beta | 1.64 | ||
Volatility % | 41.24 | ||
14-Day RSI | 25 | ||
14-Day ATR (Â¥) | 0.835401 | ||
20-Day SMA (Â¥) | 24.267 | ||
12-1 Month Momentum % | -38.07 | ||
52-Week Range (Â¥) | 21.61 - 51.271428 | ||
Shares Outstanding (Mil) | 95.77 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 8 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Nanjing Vishee Medical Technology Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Nanjing Vishee Medical Technology Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Nanjing Vishee Medical Technology Co Ltd Frequently Asked Questions
What is Nanjing Vishee Medical Technology Co Ltd(SHSE:688580)'s stock price today?
The current price of SHSE:688580 is ¥21.61. The 52 week high of SHSE:688580 is ¥51.27 and 52 week low is ¥21.61.
When is next earnings date of Nanjing Vishee Medical Technology Co Ltd(SHSE:688580)?
The next earnings date of Nanjing Vishee Medical Technology Co Ltd(SHSE:688580) is .
Does Nanjing Vishee Medical Technology Co Ltd(SHSE:688580) pay dividends? If so, how much?
The Dividend Yield %  of Nanjing Vishee Medical Technology Co Ltd(SHSE:688580) is 6.75% (As of Today), Highest Dividend Payout Ratio of Nanjing Vishee Medical Technology Co Ltd(SHSE:688580) was 1.16. The lowest was 0.36. And the median was 0.48. The  Forward Dividend Yield % of Nanjing Vishee Medical Technology Co Ltd(SHSE:688580) is 6.75%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |